Orbit. 2022 Apr;41(2):260-263. doi: 10.1080/01676830.2020.1841807. Epub 2020 Nov 10.
PMID:33172316
Chronic unilateral tearing as a sign of lacrimal sac squamous cell carcinoma.
Matos AMF, Brega DR, Gollner AM, Gonçalves ACP.
Arq Bras Oftalmol. 2021 Nov-Dec;84(6):602-605. doi: 10.5935/0004-2749.20210099.
PMID:34431882
High-risk HPV-related Squamous Cell Carcinoma in the Conjunctiva and Lacrimal sac: Clinicopathologic Characteristics and Diagnostic Utility of p16 and Rb Immunohistochemistry.
Hongo T, Yamamoto H, Tanabe M, Yasumatsu R, Kuga R, Miyazaki Y, Jiromaru R, Hashimoto K, Tateishi Y, Sonoda KH, Nakagawa T, Oda Y.
Am J Surg Pathol. 2022 Jul 1;46(7):977-987. doi: 10.1097/PAS.0000000000001857. Epub 2022 Jan 5.
Value of (18)F-FDG PET/CT for Assessment of Advanced Lacrimal Sac Non-Keratinizing Squamous Cell Carcinoma Successfully Treated with Concurrent Chemoradiotherapy.
Liao CY, Huang LA, Lin YH.
Diagnostics (Basel). 2021 Oct 22;11(11):1961. doi: 10.3390/diagnostics11111961.
PMID:34829312
Unusual presentation of HPV-positive squamous cell carcinoma of the nasolacrimal duct as carcinoma of unknown primary.